Check the time stamp on this data. Updated AI-Generated Signals for Atara Biotherapeutics Inc. (ATRA) available here: ATRA.

Atara Biotherapeutics (NASDAQ:ATRA) has announced plans to cut around 50% of its workforce, just a little over a week after it said the FDA had declined to approve its immunotherapy Ebvallo.

NEW YORK CITY, NY / ACCESS Newswire / January 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...

The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than ...

The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.

At close: January 21 at 4:00:02 PM EST ...

China 30 Year Government Bond 0.0000 1.8592% ...

Polícia encontra cerca de 7 kg de maconha com jovem que pretendia vender a droga em São Francisco Segundo a Polícia Militar, a corporação recebeu uma denúncia anônima informando que um ...